HIV activists have hailed the announcement by Gilead on Wednesday that it has authorised six generic manufacturers to sell its breakthrough HIV treatment,
Kerry Cullinan is a Deputy Editor with a focus on global health and social justice issues. Her work has appeared in publications such as Daily Maverick, where she covers topics including the COVID-19 pandemic, healthcare access, LGBTQ+ rights, and international health policy. Kerry is passionate about bringing attention to marginalized communities and advocating for equitable healthcare systems.